RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

190 hedge funds and large institutions have $4.94B invested in Ultragenyx Pharmaceutical in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 65 increasing their positions, 66 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
190
Holders Change
+18
Holders Change %
+10.47%
% of All Funds
3.91%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
33
Increased
65
Reduced
66
Closed
14
Calls
$21M
Puts
$14.1M
Net Calls
+$6.98M
Net Calls Change
+$5.91M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$600M
2
ClearBridge Investments
2
ClearBridge Investments
New York
$138M
3
BlackRock
3
BlackRock
New York
$384M
4
EAM
4
Eagle Asset Management
Florida
$20.3M
5
First Trust Advisors
5
First Trust Advisors
Illinois
$91.7M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$51.4M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$113M
3
State Street
3
State Street
Massachusetts
$155M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$48M
5
Barclays
5
Barclays
United Kingdom
$2.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
EW
201
Evoke Wealth
California
– -$1.38K -31 Closed
PFO
202
Pathstone Family Office
New Jersey
– -$1K -30 Closed
Toronto Dominion Bank
203
Toronto Dominion Bank
Ontario, Canada
– -$1K -30 Closed
5 6 7 8
9